Host-directed immune therapies: a second front in the battle against sepsis
{{output}}
Each year, sepsis claims more lives in the United States than many major cancers and HIV/AIDS combined, yet therapeutic progress has been modest. Adding to this crisis is the alarming rise of multidrug-resistant "superbugs," which increasingly render convent... ...
